Latest Biotech News

Critical regulatory changes shape the future of biomedical research and drug safety reporting. The FDA initiated daily public dissemination of adverse event reports, enhancing pharmacovigilance...

Novel scientific insights emerge across environmental and agricultural domains. Research on phytobiotic additives indicates enhanced broiler health post-pathogen challenge. DNA barcoding reveals...

Boston-based Cascala Health secured $8.6 million in seed funding to expand its AI platform targeting improvement of patient care transitions. The technology aims to reduce hospital readmissions...

Following the historic approval of Novo Nordisk's obesity drug Wegovy, stakeholders emphasize the need to identify appropriate patient populations and implement strategies for early disease...

Kriya Therapeutics completed a $313 million financing round to advance its portfolio of gene therapies targeting ophthalmic, metabolic, and neurologic chronic diseases. The investment follows...

Ionis Pharma’s Dawnzera received FDA approval as a preventive therapy for hereditary angioedema attacks, entering a competitive market dominated by Takeda’s existing medication. Clinical data...

LB Pharma is reportedly working with Leerink Partners on an initial public offering as its antipsychotic drug candidate approaches Phase III trials. This financing move aims to support late-stage...

Researchers at Uppsala University developed an AI tool that identifies subtle tissue changes indicative of prostate cancer, which were previously undetectable by pathologists. This technology...

A novel approach using deep learning enhanced multiparametric MRI habitat analysis was shown in a two-center study to predict perineural invasion in prostate cancer. This advancement may provide...

A study from Moffitt Cancer Center reveals that lymphoma induces premature aging changes in immune cells and tissues, potentially impacting patient prognosis and treatment responses. Published in...

Researchers developed a brain-delivered antibody capable of targeting pathological alpha-synuclein aggregates, which characterize synucleinopathies like Parkinson’s disease. This approach offers a...

Develop Health closed a $14.3 million Series A round led by Wing Venture Capital to enhance its platform for automating prior authorization in healthcare. By reducing administrative burdens on...

Kriya Therapeutics has raised $313 million in one of the largest 2025 biopharma funding rounds, boosting its pipeline aimed at one-time gene therapies for chronic diseases including neurologic,...

Artificial intelligence breakthroughs are transforming cancer care with novel diagnostic and therapeutic applications. Researchers have developed AI models for detecting prostate cancer overlooked...

Cutting-edge research reveals critical molecular mechanisms in various cancers, presenting new therapeutic targets. Studies identify COL6A6 as an immune-associated tumor suppressor in breast...

Significant advances illuminate mechanisms and potential interventions in neurodegenerative and neuro-oncological disorders. Neural stem cell exosomes show promise for Parkinson’s disease...

The integration of AI and robotic technologies is reshaping medical imaging and surgical interventions. An autonomous robotic system now performs expert-level carotid ultrasound leveraging...

Novel findings highlight complex immune dynamics impacting cancer immunity and therapy. Regulatory T cells expressing a FOXP3 variant can enhance cytotoxic T cell antitumor activity, with...

Artificial intelligence is driving innovation across drug discovery and genomic sciences. New AI models generate novel antibiotic structures from minimal inputs, expediting antimicrobial...

Emerging biomarkers and diagnostic platforms are reshaping clinical assessment and disease monitoring. The Pediatric Weight Questionnaire offers a standardized tool for evaluating childhood...